| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PDYN | Stock Option (right to buy) | Disposed to Issuer | -19.8K | -100% | 0 | Apr 17, 2024 | Common Stock | 19.8K | $40.20 | Direct | F1, F2 | ||
| transaction | PDYN | Stock Option (right to buy) | Award | +19.8K | 19.8K | Apr 17, 2024 | Common Stock | 19.8K | $1.59 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | 25% of the shares subject to the option vested on February 7, 2023, and thereafter 1/12 of the shares subject to the option shall vest on each quarterly vesting date, subject to the Reporting Person's continued service to the Issuer through such date. Due to a clerical error, the expiration date of the option was erroneously reported as April 1, 2032 in the Reporting Person's Form 3 filed on November 8, 2023. |
| F2 | Outstanding options were amended to reduce the exercise price and revise the vesting terms. This amendment was approved by the compensation committee of the Issuer's board of directors and is intended to be exempt pursuant to Rule 16b-3 of the Exchange Act. |
| F3 | The option is fully unvested as of the amendment. 25% of the shares subject to the option will vest on March 29, 2025, and then 1/12 of the shares subject to the option vest on each quarterly vesting date thereafter, subject to the Reporting Person's continued service to the Issuer through such date. |